This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Dexrazoxane hydrochloride is a cardioprotective drug. the dexrazoxane is used to protect the heart from cardiotoxic adverse effects of chemotherapeutic drugs, such as anthracyclines, daunorubicin, doxorubicin, etc. For the prevention of cardiomyopathy for adults and children aged 0 to 16 years, dexrazoxane was approved by the US FDA as an orphan drug for treatment with an anthracycline. Around all children are mandated to receive dexrazoxane at the discretion of the care physician starting with the first dose of anthracycline.
MARKET DYNAMICS
The dexrazoxane market is driving due to the upsurge in the number of cancer patients around the globe, there is a shift in towards using dexrazoxane in healthcare. However, high dosage, leading to side effects will hamper the market's growth. Moreover, increase in medical advances in the healthcare industry, the advancement in dexrazoxane is expected to provide opportunities in the global dexrazoxane market.
MARKET SCOPE
The "Dexrazoxane Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of dexrazoxane market with detailed market segmentation by product type and end user. The dexrazoxane market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Dexrazoxane market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The dexrazoxane market is segmented on the basis of product type and end user. Based on product type, the market is segmented as 250mg, 500mg. Based on end user, the market is segmented as hospitals, drugstores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Dexrazoxane market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Dexrazoxane market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Dexrazoxane market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dexrazoxane market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the Dexrazoxane market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Dexrazoxane market are anticipated to have lucrative growth opportunities in the future with the rising demand for Dexrazoxane in the global market. Below mentioned is the list of few companies engaged in the Dexrazoxane market.
The report also includes the profiles of key players in dexrazoxane market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc.
Gland Pharma Limited
Mylan N.V.
Pfizer Inc.
Clinigen Group plc.
Boehringer Ingelheim International GmbH
LGM Pharma
Shenzhen Haorui Industrial Dev. Co., Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Dexrazoxane Market - By Product Type
1.3.2 Dexrazoxane Market - By End User
1.3.3 Dexrazoxane Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DEXRAZOXANE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DEXRAZOXANE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DEXRAZOXANE MARKET - GLOBAL MARKET ANALYSIS
6.1. DEXRAZOXANE - GLOBAL MARKET OVERVIEW
6.2. DEXRAZOXANE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DEXRAZOXANE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. 250MG
7.3.1. Overview
7.3.2. 250mg Market Forecast and Analysis
7.4. 500MG
7.4.1. Overview
7.4.2. 500mg Market Forecast and Analysis
8. DEXRAZOXANE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. DRUGSTORES
8.4.1. Overview
8.4.2. Drugstores Market Forecast and Analysis
9. DEXRAZOXANE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Dexrazoxane Market Overview
9.1.2 North America Dexrazoxane Market Forecasts and Analysis
9.1.3 North America Dexrazoxane Market Forecasts and Analysis - By Product Type
9.1.4 North America Dexrazoxane Market Forecasts and Analysis - By End User
9.1.5 North America Dexrazoxane Market Forecasts and Analysis - By Countries
9.1.5.1 United States Dexrazoxane Market
9.1.5.1.1 United States Dexrazoxane Market by Product Type
9.1.5.1.2 United States Dexrazoxane Market by End User
9.1.5.2 Canada Dexrazoxane Market
9.1.5.2.1 Canada Dexrazoxane Market by Product Type
9.1.5.2.2 Canada Dexrazoxane Market by End User
9.1.5.3 Mexico Dexrazoxane Market
9.1.5.3.1 Mexico Dexrazoxane Market by Product Type
9.1.5.3.2 Mexico Dexrazoxane Market by End User
9.2. EUROPE
9.2.1 Europe Dexrazoxane Market Overview
9.2.2 Europe Dexrazoxane Market Forecasts and Analysis
9.2.3 Europe Dexrazoxane Market Forecasts and Analysis - By Product Type
9.2.4 Europe Dexrazoxane Market Forecasts and Analysis - By End User
9.2.5 Europe Dexrazoxane Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Dexrazoxane Market
9.2.5.1.1 Germany Dexrazoxane Market by Product Type
9.2.5.1.2 Germany Dexrazoxane Market by End User
9.2.5.2 France Dexrazoxane Market
9.2.5.2.1 France Dexrazoxane Market by Product Type
9.2.5.2.2 France Dexrazoxane Market by End User
9.2.5.3 Italy Dexrazoxane Market
9.2.5.3.1 Italy Dexrazoxane Market by Product Type
9.2.5.3.2 Italy Dexrazoxane Market by End User
9.2.5.4 Spain Dexrazoxane Market
9.2.5.4.1 Spain Dexrazoxane Market by Product Type
9.2.5.4.2 Spain Dexrazoxane Market by End User
9.2.5.5 United Kingdom Dexrazoxane Market
9.2.5.5.1 United Kingdom Dexrazoxane Market by Product Type
9.2.5.5.2 United Kingdom Dexrazoxane Market by End User
9.2.5.6 Rest of Europe Dexrazoxane Market
9.2.5.6.1 Rest of Europe Dexrazoxane Market by Product Type
9.2.5.6.2 Rest of Europe Dexrazoxane Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Dexrazoxane Market Overview
9.3.2 Asia-Pacific Dexrazoxane Market Forecasts and Analysis
9.3.3 Asia-Pacific Dexrazoxane Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Dexrazoxane Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Dexrazoxane Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Dexrazoxane Market
9.3.5.1.1 Australia Dexrazoxane Market by Product Type
9.3.5.1.2 Australia Dexrazoxane Market by End User
9.3.5.2 China Dexrazoxane Market
9.3.5.2.1 China Dexrazoxane Market by Product Type
9.3.5.2.2 China Dexrazoxane Market by End User
9.3.5.3 India Dexrazoxane Market
9.3.5.3.1 India Dexrazoxane Market by Product Type
9.3.5.3.2 India Dexrazoxane Market by End User
9.3.5.4 Japan Dexrazoxane Market
9.3.5.4.1 Japan Dexrazoxane Market by Product Type
9.3.5.4.2 Japan Dexrazoxane Market by End User
9.3.5.5 South Korea Dexrazoxane Market
9.3.5.5.1 South Korea Dexrazoxane Market by Product Type
9.3.5.5.2 South Korea Dexrazoxane Market by End User
9.3.5.6 Rest of Asia-Pacific Dexrazoxane Market
9.3.5.6.1 Rest of Asia-Pacific Dexrazoxane Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Dexrazoxane Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Dexrazoxane Market Overview
9.4.2 Middle East and Africa Dexrazoxane Market Forecasts and Analysis
9.4.3 Middle East and Africa Dexrazoxane Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Dexrazoxane Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Dexrazoxane Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Dexrazoxane Market
9.4.5.1.1 South Africa Dexrazoxane Market by Product Type
9.4.5.1.2 South Africa Dexrazoxane Market by End User
9.4.5.2 Saudi Arabia Dexrazoxane Market
9.4.5.2.1 Saudi Arabia Dexrazoxane Market by Product Type
9.4.5.2.2 Saudi Arabia Dexrazoxane Market by End User
9.4.5.3 U.A.E Dexrazoxane Market
9.4.5.3.1 U.A.E Dexrazoxane Market by Product Type
9.4.5.3.2 U.A.E Dexrazoxane Market by End User
9.4.5.4 Rest of Middle East and Africa Dexrazoxane Market
9.4.5.4.1 Rest of Middle East and Africa Dexrazoxane Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Dexrazoxane Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Dexrazoxane Market Overview
9.5.2 South and Central America Dexrazoxane Market Forecasts and Analysis
9.5.3 South and Central America Dexrazoxane Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Dexrazoxane Market Forecasts and Analysis - By End User
9.5.5 South and Central America Dexrazoxane Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Dexrazoxane Market
9.5.5.1.1 Brazil Dexrazoxane Market by Product Type
9.5.5.1.2 Brazil Dexrazoxane Market by End User
9.5.5.2 Argentina Dexrazoxane Market
9.5.5.2.1 Argentina Dexrazoxane Market by Product Type
9.5.5.2.2 Argentina Dexrazoxane Market by End User
9.5.5.3 Rest of South and Central America Dexrazoxane Market
9.5.5.3.1 Rest of South and Central America Dexrazoxane Market by Product Type
9.5.5.3.2 Rest of South and Central America Dexrazoxane Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DEXRAZOXANE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DEXRAZOXANE MARKET, KEY COMPANY PROFILES
12.1. HIKMA PHARMACEUTICALS PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CUMBERLAND PHARMACEUTICALS INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAND PHARMA LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MYLAN N.V.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PFIZER INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CLINIGEN GROUP PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LGM PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SHENZHEN HAORUI INDUSTRIAL DEV. CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
